| |
|
|
|
Cleveland Biolabs  
|
|
2.64 -0.52 (-0.16%) |
10-22 16:00 |
|
Open: |
3.07 |
Pre close: |
3.16 |
Target:
|
4.74
|
|
High: |
3.16 |
Low: |
2.6 |
Resistance:
|
4.06
5.43
|
|
Volume: |
967,482 |
Market Cap: |
34M |
Support:
|
1.85
1.54
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.68
 |
MACD |
MACD(12,26):
|
0.17 |
|
MA(20): |
2.23 |
Signal(12,26,9): |
0.08 |
|
MA(100): |
2.21 |
Stochastic Oscillator |
%K(14,3):
|
31.65  |
|
MA(250): |
1.82 |
%D(3): |
44.63 |
|
Average Volume(K) |
3-Month: |
272457
|
52-Week |
High:
|
5.43 |
|
10-Days: |
1525381 |
Low: |
0.50 |
|
RSI |
RSI(14):
|
59.17 |
Change(%): |
277.1 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.184 |
Return on Equity (ttm) |
-79.0 |
Shares Out. (M) |
12.92 |
|
EPS Est. Current Year |
-0.160 |
Return on Assets (ttm) |
-32.0 |
Shares Float (M) |
5.67 |
|
EPS Est. Next Year |
-0.480 |
PEG Ratio |
0.00 |
% Held by Insiders |
64.39 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
-77.2 |
% Held by Institutions |
3.68 |
|
Forward EPS |
-0.280 |
Gross Profit (p.s.) |
-0.042 |
Shares Short (K) |
270 |
|
Book Value (p.s.) |
-0.130 |
EBITDA (p.s.) |
-0.141 |
P/E |
-14.35 |
|
Sales Per Share |
0.066 |
Qtrly Earnings Growth |
0.00 |
P/BV |
-20.31 |
|
Profit Margin |
-246.62 |
Operating Cash Flow
(M) |
-1.98 |
P/S |
39.76 |
|
Operating Margin |
-213.98 |
Levered Free Cash Flow
(M) |
-1.44 |
P/CF |
-17.23 |
|
|
|
|
|
|
